|
|
|
|
LEADER |
00000ngm a2200000 a 4500 |
003 |
UkLoHST |
005 |
20230713150110.0 |
006 |
m c |
007 |
cr|cna|||a|||| |
007 |
vz|czazum |
008 |
230704s2023 enk052 | |o v|eng d |
028 |
5 |
0 |
|a 6030
|b Henry Stewart Talks
|
035 |
|
|
|a (HSTalks)HST6030
|
040 |
|
|
|a HSTalks
|b eng
|d ATU
|
100 |
1 |
|
|a Schoenfeld, Jonathan D.,
|e speaker
|
245 |
1 |
0 |
|a Immunotherapy and radiation for head and neck cancers /
|c Jonathan D. Schoenfeld.
|
264 |
|
1 |
|a London :
|b Henry Stewart Talks,
|c 2023.
|
300 |
|
|
|a 1 streaming video file (52 min.) :
|b color, sound.
|
336 |
|
|
|a two-dimensional moving image
|b tdi
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
344 |
|
|
|a digital
|
347 |
|
|
|a video file
|b MPEG-4
|
490 |
1 |
|
|a The biomedical & life sciences collection,
|x 2056-452X
|
500 |
|
|
|a Animated audio-visual presentation with synchronized narration.
|
500 |
|
|
|a Title from title frames.
|
505 |
0 |
|
|a Contents: Head and neck cancer -- PD-1 blockade -- Predictive markers -- PDL1 expression and HPV status -- Keynote 48 -- Neoadjuvant immunotherapy -- Immunotherapy trials -- Keynote 689 -- IAP inhibitors.
|
538 |
|
|
|a Mode of access: World Wide Web.
|
650 |
|
0 |
|a Cancer
|x Immunotherapy.
|9 326546
|
650 |
|
0 |
|a Cancer
|x Radiotherapy.
|9 314969
|
650 |
|
0 |
|a Head
|x Cancer
|x Treatment.
|9 760005
|
650 |
|
0 |
|a Neck
|x Cancer
|x Treatment.
|9 760012
|
650 |
|
2 |
|a Head and Neck Neoplasms
|x immunology.
|9 518857
|
650 |
|
2 |
|a Head and Neck Neoplasms
|x therapy.
|9 515980
|
650 |
|
2 |
|a Immunotherapy.
|9 362569
|
650 |
|
2 |
|a Neoadjuvant Therapy.
|9 365295
|
650 |
|
2 |
|a Radiotherapy.
|9 360138
|
830 |
|
0 |
|a Henry Stewart talks.
|p Biomedical & life sciences collection.
|
856 |
4 |
0 |
|u http://ezproxy.aut.ac.nz/login?url=https://hstalks.com/bs/5322/
|z Henry Stewart Talks: Biomedical & Life Sciences
|
942 |
|
|
|c SV
|
999 |
|
|
|c 1843986
|d 1843986
|